Page last updated: 2024-08-24

telmisartan and Hypercholesterolemia

telmisartan has been researched along with Hypercholesterolemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, JC; Cha, DH; Cho, SK; Jeon, DW; Kim, KH; Kim, SY; Kim, TS; Kim, WS; Kim, YJ; Lee, HC; Oh, YS; Park, DG; Park, SH; Rha, SW; Rhee, MY; Sung, KC; Yoo, BS; Yoo, KD; Yoon, MH; Yoon, YW1
Ambrosioni, E; Borghi, C; Cicero, AF; Di Gregori, V; Prandin, MG; Veronesi, M1
Abe, S; Inoue, T; Node, K; Sakuma, M; Taguchi, I; Toyoda, S1
Bian, C; Chen, P; Hu, HQ; Li, XC; Lin, J; Wang, YF1

Trials

3 trial(s) available for telmisartan and Hypercholesterolemia

ArticleYear
Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study.
    Clinical therapeutics, 2019, Volume: 41, Issue:4

    Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Double-Blind Method; Drug Combinations; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Rosuvastatin Calcium; Telmisartan; Treatment Outcome

2019
Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.
    Fundamental & clinical pharmacology, 2009, Volume: 23, Issue:5

    Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Anticholesteremic Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Bisoprolol; Blood Pressure; Cross-Over Studies; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Aged; Receptor, Angiotensin, Type 1; Simvastatin; Telmisartan; Treatment Outcome; Young Adult

2009
Inhibition of intestinal cholesterol absorption might explain cholesterol-lowering effect of telmisartan.
    Journal of clinical pharmacy and therapeutics, 2011, Volume: 36, Issue:1

    Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Anticholesteremic Agents; Benzimidazoles; Benzoates; Biomarkers; Cholestanol; Cholesterol; Cholesterol, LDL; Fatty Acids, Monounsaturated; Female; Fluvastatin; Gastrointestinal Agents; Humans; Hypercholesterolemia; Hypertension; Indoles; Intestinal Absorption; Male; Middle Aged; PPAR gamma; Telmisartan

2011

Other Studies

1 other study(ies) available for telmisartan and Hypercholesterolemia

ArticleYear
Telmisartan-enhanced hypercholesterolaemic serum-induced vascular endothelial growth factor expression in immortalized human umbilical vascular endothelial cells.
    Scandinavian journal of clinical and laboratory investigation, 2007, Volume: 67, Issue:6

    Topics: Androstadienes; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Endothelium, Vascular; Humans; Hypercholesterolemia; Male; Neovascularization, Physiologic; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Rabbits; Signal Transduction; Telmisartan; Umbilicus; Up-Regulation; Vascular Endothelial Growth Factor A; Wortmannin

2007